These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 30707297

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.
    Wang S, Li Y, Shi H, Scarpellini G, Torres-Escobar A, Roland KL, Curtiss R.
    Infect Immun; 2010 Jul; 78(7):3258-71. PubMed ID: 20479086
    [Abstract] [Full Text] [Related]

  • 24. Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice.
    Piao Z, Akeda Y, Takeuchi D, Ishii KJ, Ubukata K, Briles DE, Tomono K, Oishi K.
    Vaccine; 2014 Sep 29; 32(43):5607-13. PubMed ID: 25132335
    [Abstract] [Full Text] [Related]

  • 25. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae.
    Xu J, Dai W, Wang Z, Chen B, Li Z, Fan X.
    Clin Vaccine Immunol; 2011 Jan 29; 18(1):75-81. PubMed ID: 21047997
    [Abstract] [Full Text] [Related]

  • 26. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB, Carter AT, Hitchin E, Wells JM.
    J Infect Dis; 2007 Jan 15; 195(2):185-93. PubMed ID: 17191163
    [Abstract] [Full Text] [Related]

  • 27. Preparation and immunogenicity of capsular polysaccharide-surface adhesin A (PsaA) conjugate of Streptococcuspneumoniae.
    Lin H, Lin Z, Meng C, Huang J, Guo Y.
    Immunobiology; 2010 Jul 15; 215(7):545-50. PubMed ID: 19880214
    [Abstract] [Full Text] [Related]

  • 28. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
    Kothari N, Kothari S, Choi YJ, Dey A, Briles DE, Rhee DK, Carbis R.
    Vaccine; 2015 Feb 04; 33(6):783-8. PubMed ID: 25545593
    [Abstract] [Full Text] [Related]

  • 29. Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses.
    Miyaji EN, Dias WO, Tanizaki MM, Leite LC.
    FEMS Immunol Med Microbiol; 2003 Jun 10; 37(1):53-7. PubMed ID: 12770760
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.
    Yamamoto M, McDaniel LS, Kawabata K, Briles DE, Jackson RJ, McGhee JR, Kiyono H.
    Infect Immun; 1997 Feb 10; 65(2):640-4. PubMed ID: 9009325
    [Abstract] [Full Text] [Related]

  • 33. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
    Goulart C, Rodriguez D, Kanno AI, Converso TR, Lu YJ, Malley R, Leite LCC.
    Clin Vaccine Immunol; 2017 Oct 10; 24(10):. PubMed ID: 28768668
    [Abstract] [Full Text] [Related]

  • 34. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).
    Talkington DF, Brown BG, Tharpe JA, Koenig A, Russell H.
    Microb Pathog; 1996 Jul 10; 21(1):17-22. PubMed ID: 8827703
    [Abstract] [Full Text] [Related]

  • 35. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
    Ferreira DM, Darrieux M, Oliveira ML, Leite LC, Miyaji EN.
    Clin Vaccine Immunol; 2008 Mar 10; 15(3):499-505. PubMed ID: 18184825
    [Abstract] [Full Text] [Related]

  • 36. Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA, Lingnau K, Nagy E, Jonsdottir I.
    Infect Immun; 2012 Jan 10; 80(1):461-8. PubMed ID: 22025519
    [Abstract] [Full Text] [Related]

  • 37. Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.
    Oliveira ML, Miyaji EN, Ferreira DM, Moreno AT, Ferreira PC, Lima FA, Santos FL, Sakauchi MA, Takata CS, Higashi HG, Raw I, Kubrusly FS, Ho PL.
    PLoS One; 2010 May 27; 5(5):e10863. PubMed ID: 20523738
    [Abstract] [Full Text] [Related]

  • 38. Expression, purification, and characterization of pneumococcal PsaA-PspA fusion protein.
    Guo X, Sun Q, Xi H, Zhang Y, Guo M, Zhang C, Zhu S, Gu T, Kong W, Wu Y.
    Protein Expr Purif; 2021 Feb 27; 178():105782. PubMed ID: 33122039
    [Abstract] [Full Text] [Related]

  • 39. Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.
    Salcedo-Rivillas C, Debrie AS, Miyaji EN, Ferreira JM, Raw I, Locht C, Ho PL, Mielcarek N, Oliveira ML.
    Clin Vaccine Immunol; 2014 Jul 27; 21(7):972-81. PubMed ID: 24807055
    [Abstract] [Full Text] [Related]

  • 40. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
    Schmid P, Selak S, Keller M, Luhan B, Magyarics Z, Seidel S, Schlick P, Reinisch C, Lingnau K, Nagy E, Grubeck-Loebenstein B.
    Vaccine; 2011 May 23; 29(23):3982-9. PubMed ID: 21481328
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.